现代中西医结合杂志
現代中西醫結閤雜誌
현대중서의결합잡지
MODERN JOURNAL OF INTEGRATED TRADITIONAL CHINESE AND WESTERN MEDICINE
2014年
35期
3880-3882
,共3页
侯文华%陈洪涛%苗永国%张明明%刘建娟%李景章
侯文華%陳洪濤%苗永國%張明明%劉建娟%李景章
후문화%진홍도%묘영국%장명명%류건연%리경장
高血压%阿托伐他汀%肿瘤坏死因子%白细胞介素
高血壓%阿託伐他汀%腫瘤壞死因子%白細胞介素
고혈압%아탁벌타정%종류배사인자%백세포개소
hypertension%atorvastatin%endothelial progenitor cells%tumor necrosis factor%interleukin
目的:探讨阿托伐他汀对原发性高血压患者肿瘤坏死因子-α(TNF -α)、白介素-6(IL -6)、超敏 C 反应蛋白(hs -CRP)和血管内皮舒张功能的影响。方法选取原发性高血压患者50例,随机分为2组,常规组25例予常规降压药物治疗,实验组25例予常规降压药物联合阿托伐他汀治疗。分别于治疗前和治疗后检测2组患者的血压、低密度脂蛋白(LDL)、总胆固醇(TC)、三酰甘油(TG)、TNF -α、 IL -6、hs- CRP 和血管内皮舒张功能情况。结果治疗8周后常规组和实验组收缩压均显著降低(P 均<0.05),且实验组收缩压降低程度明显大于常规组(P <0.05);实验组 LDL、TC 和 TG 均明显下降(P 均<0.05),血管内皮舒张功能亦获得明显改善(P <0.05);2组 TNF -α、IL -6和 hs -CRP 水平较前均显著降低(P均<0.05),且实验组各指标下降幅度均较常规组更大(P 均<0.05)。结论对于原发性高血压患者,在常规口服降压药物的同时联合使用阿托伐他汀,可明显降低血压,并明显降低血脂、抑制炎症因子及改善患者血管内皮功能。
目的:探討阿託伐他汀對原髮性高血壓患者腫瘤壞死因子-α(TNF -α)、白介素-6(IL -6)、超敏 C 反應蛋白(hs -CRP)和血管內皮舒張功能的影響。方法選取原髮性高血壓患者50例,隨機分為2組,常規組25例予常規降壓藥物治療,實驗組25例予常規降壓藥物聯閤阿託伐他汀治療。分彆于治療前和治療後檢測2組患者的血壓、低密度脂蛋白(LDL)、總膽固醇(TC)、三酰甘油(TG)、TNF -α、 IL -6、hs- CRP 和血管內皮舒張功能情況。結果治療8週後常規組和實驗組收縮壓均顯著降低(P 均<0.05),且實驗組收縮壓降低程度明顯大于常規組(P <0.05);實驗組 LDL、TC 和 TG 均明顯下降(P 均<0.05),血管內皮舒張功能亦穫得明顯改善(P <0.05);2組 TNF -α、IL -6和 hs -CRP 水平較前均顯著降低(P均<0.05),且實驗組各指標下降幅度均較常規組更大(P 均<0.05)。結論對于原髮性高血壓患者,在常規口服降壓藥物的同時聯閤使用阿託伐他汀,可明顯降低血壓,併明顯降低血脂、抑製炎癥因子及改善患者血管內皮功能。
목적:탐토아탁벌타정대원발성고혈압환자종류배사인자-α(TNF -α)、백개소-6(IL -6)、초민 C 반응단백(hs -CRP)화혈관내피서장공능적영향。방법선취원발성고혈압환자50례,수궤분위2조,상규조25례여상규강압약물치료,실험조25례여상규강압약물연합아탁벌타정치료。분별우치료전화치료후검측2조환자적혈압、저밀도지단백(LDL)、총담고순(TC)、삼선감유(TG)、TNF -α、 IL -6、hs- CRP 화혈관내피서장공능정황。결과치료8주후상규조화실험조수축압균현저강저(P 균<0.05),차실험조수축압강저정도명현대우상규조(P <0.05);실험조 LDL、TC 화 TG 균명현하강(P 균<0.05),혈관내피서장공능역획득명현개선(P <0.05);2조 TNF -α、IL -6화 hs -CRP 수평교전균현저강저(P균<0.05),차실험조각지표하강폭도균교상규조경대(P 균<0.05)。결론대우원발성고혈압환자,재상규구복강압약물적동시연합사용아탁벌타정,가명현강저혈압,병명현강저혈지、억제염증인자급개선환자혈관내피공능。
Objective To investigate the effect of atorvastatin on TNF -α、IL -6、hs -CRP and endothelial function in pa-tients with hypertension.Methods A total of 50 patients who had essential hypertension were recruited.They were randomly divided into conventional group (who received conventional anti-hypertensive drugs, n =25) and experiment group (who re-ceived conventional anti-hypertensive drugs combined with atorvastatin treatment, n =25).The changes of blood pressure, blood lipids and vascular endothelial function were recorded before and after the treatment.Results After a -8 -week regular treatment, both the conventional group and experiment group had a more lower blood pressure when compared with the previous level (P <0.05).The blood pressure decreased (31.25 ±4.14) mmHg in conventional group and (37.83 ±6.19) mmHg in experiment group, there was significant difference between the 2 groups (P <0.05).Both of the 2 groups had a significant de-crease in TNF -α, IL -6 and hs -CRP(P <0.05), but the experiment group had a more ideal recovery in these index(P <0.05).Only the experiment group had an improvement in LDL,TC ,TG amd vascular endothelial function (P <0.05).Con-clusions:For essential hypertension patients, conventional anti-hypertensive drugs combined with atorvastatin treatment not on-ly could improve the the blood lipids, inflammatory cytokines level and vascular endothelial function, but also obtain a more preferable blood pressure control.